SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-172995"
 

Search: onr:"swepub:oai:DiVA.org:liu-172995" > Monitoring metaboli...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples

Leong, Huey Sze (author)
Univ Technol Sydney, Australia; Univ Sydney, Australia
Watanabe, Shimpei (author)
Linköpings universitet,Avdelningen för läkemedelsforskning,Medicinska fakulteten,Natl Board Forens Med, Deparment Forens Genet & Forens Toxicol, Artillerigatan 12, S-58758 Linkoping, Sweden; RIKEN, Japan
Kuzhiumparambil, Unnikrishnan (author)
Univ Technol Sydney, Australia
show more...
Fong, Ching Yee (author)
Hlth Sci Author, Singapore
Moy, Hooi Yan (author)
Hlth Sci Author, Singapore
Yao, Yi Ju (author)
Hlth Sci Author, Singapore
Witting, Paul K. (author)
Univ Sydney, Australia
Fu, Shanlin (author)
Univ Technol Sydney, Australia
show less...
 (creator_code:org_t)
2020-12-29
2021
English.
In: Forensic Toxicology. - : SPRINGER. - 1860-8965 .- 1860-8973. ; 39:1, s. 198-212
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Purpose A tert-leucinate derivative synthetic cannabinoid, methyl (2S)-2-([1-(4-fluorobutyl)-1H-indazole-3-carbonyl]amino)-3,3-dimethylbutanoate (4F-MDMB-BINACA, 4F-MDMB-BUTINACA or 4F-ADB) is known to adversely impact health. This study aimed to evaluate the suitability of three different modes of monitoring metabolism: HepG2 liver cells, fungus Cunninghamella elegans (C. elegans) and pooled human liver microsomes (HLM) for comparison with human in-vivo metabolism in identifying suitable urinary marker(s) for 4F-MDMB-BINACA intake. Methods Tentative structure elucidation of in-vitro metabolites was performed on HepG2, C. elegans and HLM using liquid chromatography-tandem mass spectrometry and high-resolution mass spectrometry analysis. In-vivo metabolites obtained from twenty authentic human urine samples were analysed using liquid chromatography-Orbitrap mass spectrometry. Results Incubation with HepG2, C. elegans and HLM yielded nine, twenty-three and seventeen metabolites of 4F-MDMB-BINACA, respectively, formed via ester hydrolysis, hydroxylation, carboxylation, dehydrogenation, oxidative defluorination, carbonylation or reaction combinations. Phase II metabolites of glucosidation and sulfation were also exclusively identified using C. elegans model. Eight in-vivo metabolites tentatively identified were mainly products of ester hydrolysis with or without additional dehydrogenation, N-dealkylation, monohydroxylation and oxidative defluorination with further oxidation to butanoic acid. Metabolites with intact terminal methyl ester moiety, i.e., oxidative defluorination with further oxidation to butanoic acid, were also tentatively identified. Conclusions The in-vitro models presented proved useful in the exhaustive metabolism studies. Despite limitations, HepG2 identified the major 4F-MDMB-BINACA ester hydrolysis metabolite, and C. elegans demonstrated the capacity to produce a wide variety of metabolites. Both C. elegans and HLM produced all the in-vivo metabolites. Ester hydrolysis and ester hydrolysis plus dehydrogenation 4F-MDMB-BINACA metabolites were recommended as urinary markers for 4F-MDMB-BINACA intake.

Subject headings

NATURVETENSKAP  -- Kemi -- Analytisk kemi (hsv//swe)
NATURAL SCIENCES  -- Chemical Sciences -- Analytical Chemistry (hsv//eng)

Keyword

4F-MDMB-BINACA metabolism; 4F-MDMB-BUTINACA (4F-ADB); HepG2; Cunninghamella elegans; Human liver microsomes; Urinary marker of 4F-MDMB-BINACA intake

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view